Agilent Advanced Therapeutics Click to Edit Master Title Style Strategic Growth in Specialty CDMO March 27, 2026 Click to edit Master subtitle style Safe harbor This presentation contains forward-looking statements (including, without limitation, statements on Agilent's (the "company" or "our") strategy, priorities, growth and growth opportunities, productivity, reinvestment, customer focus, evolving product mix, work environment and innovation plans; our revenue, revenue growth, operating margin and margin ...